Abstract Differentiating viral from bacterial causes of acute respiratory illness can avoid the numerous consequences of inappropriate antibiotic use. We review the clinical literature evaluating a combined rapid Myxovirus resistance protein A and C-reactive protein point-of-care assay, discusses potential applications and highlight remaining questions.